Events Partner Content 3rd B & T Cell-Mediated Autoimmune Disease Drug Development ... Industry-led forum focused on B & T Cell Collaboration
News Alpha-9's $175m third-round heads latest biotech financings Radiopharma startup Alpha-9 Oncology has closed a sizeable third investment round, heading a list of recent financings that also feature Axonis, Kivu Bio, SynOx, Agomab, and Blue Earth Ther
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.
